Purina says the foods contain adjusted and graded levels of protein and phosphorus to address the delicate balance of providing needed protein in older cats against uraemic toxin production in late phase renal decline.
The current advice is that phosphate should be restricted when the renal patient has confirmed CKD, and IRIS provides therapeutic serum phosphate targets for each stage.
Dr Ellie Groves BA(Hons) VetMB MRCVS, Purina Technical Manager for the UK and Ireland, said: “As obligate carnivores, cats have a high requirement for protein, however, around 20% of senior cats have decreased ability to digest protein, and so are absorbing less protein.
"An inadequate intake of protein leads to loss of lean body mass as muscle is catabolised to meet this need.
"We know that this loss of lean body mass is significantly correlated with an increased risk of mortality.
"But we need to be careful – in renal disease, there is the potential for protein breakdown products to increase in the circulation, acting as toxins.
"So, we need to fine-tune the amount of protein, depending on the stage of chronic renal insufficiency (CRI).
"A dual approach, with Early and Advanced products, allows tailoring of protein levels.”
“Alongside protein, phosphorus content is also tailored to the stage of kidney decline.
"Restricting phosphorus can slow the progression of chronic kidney disease by reducing morphological damage to the kidneys and is thought to be the most important influencer of survival in cats with CKD.
"The levels of phosphorus in the products, are tailored, alongside the protein, to reflect the needs of the cat, with increased restriction when cats are in advanced decline and the kidneys are struggling most.”
NF Renal Function Early Care is available in a dry format (1.5kg) and a pouch (tender pieces with chicken 85g).
NF Renal Function Advanced Care is available in 1.5kg and 5kg packs of dry food, and ‘wet’ options of tender pieces with chicken/ salmon (85g pouches) and a mousse (195g can).
Both diets are now available in veterinary wholesalers.
Fort Dodge has announced that a challenge study has demonstrated the ability of Duvaxyn® IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Sydney/07 (H3N8) two weeks after a two dose primary course. This strain was responsible for the financially devastating equine influenza outbreak in Australia in August 2007.
Duvaxyn IE-T Plus is an inactivated whole virus equine influenza vaccine, adjuvanted with an aqueous-based adjuvant. According to Fort Dodge, experts at a recent WHO meeting on human vaccines expressed the view that whole virus vaccines have the potential to induce a stronger and more broadly based response to circulating influenza strains than those contained in sub-unit vaccines because of the presence of the full set of virus proteins in the vaccine*.
The study, conducted by the Animal Health Trust, involved two groups of EIV seronegative horses. The first group, consisting of seven vaccinates, were given two dose of Duvaxyn IE-T Plus, 28 days apart, and challenged with A/equi-2/Sydney/07 (H3N8) virus strain 14 days after the second vaccination. The second group of unvaccinated horses was challenged at the same time. Duvaxyn IE-T Plus caused a statistically significant reduction in both clinical signs of the disease and in viral shedding.
Helen Barnes, EMEA Equine Business Manager for Fort Dodge, said: "The results of this challenge study provide reassurance for owners that horses vaccinated with Duvaxyn will be protected against circulating strains of equine influenza, including the Sydney strain which proved so damaging.
"As the benefits offered by whole virus technology are increasingly recognised, the popularity of vaccines based on this technology is re-emerging, particularly to combat a potential pandemic.
"The entire Duvaxyn range of equine vaccines, including the recently licensed Duvaxyn WNV for West Nile Virus, are based on the whole virus approach as we believe it offers a broad and consistent level of protection."
Petplan has announced the finalists for the 2012 Petplan Veterinary Awards.
According to the company, the awards have been more popular than ever, with over 3,000 nominations submitted for exceptional veterinary staff across the UK.
The finalists for each of the categories are:
Vet of the YearZaila Dunbar, Queens Park Veterinary Practice - London Tony Barnes, Manor Veterinary Clinic - FolkestoneMark Taylor, Feldon Veterinary Centre - Bedworth
Vet Nurse of the YearLucy Kells, The Wildlife Aid Foundation - LeatherheadRachael Harris, Elms Veterinary Surgery - MonmouthSarah Algar, Brentknoll Veterinary Centre Ltd - Worcester
Support Staff of the YearSarah Bowler, Holly House Veterinary Surgery - KnutsfordJane Wyatt, George Hunt and Son - PoyntonCathy Campbell, Haygate Veterinary Centre - Telford
Vet Practice of the YearEastcott Veterinary Clinic and Hospital - SwindonPrince Bishop Veterinary Hospital - County DurhamBroadleys Veterinary Hospital - Stirling
Simon Masding, Petplan's Head of Sales and Partnerships, said: "The Vet of the Year Awards are the highlight of our Petplan calendar because they recognise the dedication that the veterinary industry puts into providing the nation's pets with the best possible treatment. Each year the nominations reach an even higher standard and we're delighted with this year's finalists. At Petplan we work with more veterinary professionals than any other insurance provider and it is through these awards that we thank the profession on behalf of UK pet owners."
Petplan has also announced that comedian Seann Walsh, known for his appearances on shows like Mock the Week and Michael McIntyre's Comedy Roadshow, will be this year's compère for the Vet of the Year Awards. Following in the footsteps of previous compères Michael McIntyre, Alistair McGowan, Frankie Boyle and Jason Manford; he will be entertaining this year's guests on the 12th April at Birmingham Town Hall.
For further information visit www.petplan.co.uk/vetawards/
The government estimates that up to 5,000 primates are currently kept outside of licensed zoos in the UK. Marmosets are by far the most commonly held primates in the UK, with capuchins, squirrel monkeys, lemurs and tamarins also among the most common species.
The new proposals will mean that specialist primate keepers who do not hold a zoo licence will need to obtain a new specialist private primate keeper licence to ensure they are meeting the required high welfare standards. These plans will also place welfare restrictions on the breeding and transferring of primates.
The BVA has welcomed the consultation. BVA Senior Vice President, Daniella Dos Santos said: “For a long time, we have called for a ban on private individuals keeping primates as pets. As vets, we have significant concerns as to whether the health and welfare needs of primates can ever be met under these circumstances.
“Primates are long-lived, intelligent and socially complex animals whose needs are extraordinarily difficult to meet in captivity and we can think of no circumstances where a primate would benefit from being kept in this way.
“We welcome the Government’s move to open a public consultation on this and hope that it does indeed result in a ban. If the UK wants to maintain its reputation for some of the highest standards of animal welfare in the world and if the government wants to fulfil its promises of enhancing the welfare of animals as we leave Europe then we must put an end to the keeping and trade of primates as pets.”
To take part in the consultation, visit: https://consult.defra.gov.uk/animal-health-and-welfare/primates-as-pets-in-england/consultation/intro/
The Committee has been named after the Supplementary Royal Charter 2015 which broadened the functions of the RCVS and allowed for a more flexible approach when dealing with complaints about professional conduct.
The Charter Case Committee can resolve cases where the conduct of a veterinary surgeon or nurse has fallen far below the level of conduct expected of them, but not so far as to warrant a full, public Disciplinary Committee hearing.
The Committee can deal with such cases without the need for a public hearing and can give veterinary surgeons or nurses either a confidential or a public warning about their future conduct.
A warning issued by the Charter Case Committee does not affect the individual’s registration status or their right to practise.
Eleanor Ferguson, RCVS Registrar, said: “The establishment of the Charter Case Committee plays a vitally important role in balancing our statutory role of upholding professional conduct standards and protecting animal health and welfare and public confidence in the professions, with our mission to become a compassionate regulator.
“The Charter Case Committee Protocol allows for the alternative resolution of certain cases where a veterinary surgeon or veterinary nurse has engaged in behaviour that amounts to serious professional misconduct or has been convicted of an offence, but where it is not in the public interest for the matter to be referred to a hearing of the Disciplinary Committee because it is at the lower end of seriousness.
“The type of cases we envisage being dealt with by the Committee are those where the Code has been breached but where there is no ongoing risk to animal welfare or public confidence, and where the level of insight and personal reflection regarding their conduct is such that it can be resolved without the need for an onerous, stressful and expensive Disciplinary Committee hearing.
"We estimate that the CCC will deal with around 20 such cases per year.
“The most serious cases of professional misconduct will, of course, continue to be referred to Disciplinary Committee hearings.”
https://www.rcvs.org.uk/who-we-are/committees/charter-case-committee.
Production company Keo Films is on the hunt for a veterinary surgeon that wants to take a year out and help set up a new community in a remote part of the British Isles for a high profile TV documentary series.
The documentary is essentially a social experiment to see whether it is possible to begin again, away from the conveniences and technology of the modern world.
Keo Films, which was behind such programmes as River Cottage and Welcome to Rio, tells VetSurgeon.org that they've already had applications from people working in a variety of fields, including doctors, builders and engineers. For obvious reasons, they are very keen to recruit a veterinary surgeon.
There is no payment for appearing in the documentary. Still, it might be just the thing for someone who needs a break from it all. And who knows, it might lead to a second career opening supermarkets at the weekend!
If you're interested, or know someone else who might be, contact eden@keofilms.com or call 020 7490 3580
Over the next few weeks, experts from the fields of veterinary science, academia and government will be offering sector-specific insight into key achievements, latest research and future action needed to tackle AMR through a number of blog posts published on www.bva.co.uk/BVA-blog.
Bloggers will include BVA President John Fishwick, presidents of several BVA specialist divisions, leading academics, and heads of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and the National Office of Animal Health (NOAH), among others.
AMR poses a global threat to human and animal health and requires concerted efforts across the medical and veterinary professions to steward responsible use and prescription, as recognised in the UK Government-commission global Review on Antimicrobial Resistance, chaired by Lord O’Neill (May 2016).
The veterinary profession in the UK has been committed to the responsible use of antimicrobials, with the Chief Medical Officer publicly recognising the concerted efforts to reduce antibiotic usage in agriculture. BVA is a member of RUMA and has been working closely with stakeholders in government and industry to develop appropriate and evidence based targets across the livestock sector, which will be announced tomorrow (27 October) at a conference in London.
British Veterinary Association Senior Vice President Gudrun Ravetz said: "AMR is a serious global One Health issue that the veterinary profession is deeply concerned about, as it threatens our ability to treat animals and protect human health, and it is an issue BVA is addressing through joined-up working with UK governments, industry and other health sectors. Increased collaboration between the health sectors, underpinned by a commitment from each of us within the veterinary profession to maintain the highest standards of stewardship in using antimicrobials, most especially Critically Important Antibiotics, is the only way we can preserve these essential medicines for future generations.
"The blog series highlights various aspects of AMR by experts in their field, and we hope that throwing a spotlight on various sectors’ achievements so far and suggested steps for the future will help keep this important issue on all of our agendas, where it should be."
AMR discussions will continue at BVA Congress at the London Vet Show (16-17 November) with a Friday afternoon session on ‘The psychology of antimicrobial resistance: what can social science tell us?’, featuring David Brodbelt, Professor of Evidence-based Veterinary Medicine at Royal Veterinary College; Ian Donald,Emeritus Professor of Psychology and Director, Mulberry Research & Consulting Ltd, and Kristen Reyher, Senior Lecturer in Farm Animal Science at the University of Bristol.
To read Nigel Gibbens’s blog and other blogs from the series, see https://www.bva.co.uk/news-campaigns-and-policy/bva-community/bva-blog/safeguarding-the-future-of-antibiotics-is-our-moral-responsibility-as-vets/ and follow the ‘#AMRinfocus’ hashtag on social media.
Sophia Salmon MRCVS from Central CPD said: "All of the major corporate chains in the UK now deliver a significant proportion of their clinical and non-clinical staff training via online learning platforms. These systems form an important part of professional development, training standardisation and even performance evaluation.
"However, learning platforms can be expensive to procure and develop, as well as being time-consuming to maintain, and therefore may not be viable for smaller businesses."
Central CPD has used its experience providing online learning to several of the UK’s major corporate veterinary groups to create 'Central CPD On-Demand', which features over 1500 clinical and non-clinical CPD videos for vets, nurses, managers and receptionists.
There's a new practice subscription package which, developed with whole-team learning in mind, costs £2000 per year for up to twenty people (veterinary surgeons, nurses or management staff).
Central CPD says the new package allows individuals and practices to set their own learning plan for the year, and for mentors to build and supervise training programmes for other staff members.
Practices can add their own content, such as policy documents, in order to assist with the delivery of compulsory elements of staff training.
Central CPD says its service is a fraction of the cost of procuring and populating an off-the-shelf learning platform, and the company is staffed by vets and vet nurses who are available to provide one-to-one advice and support to help practices set up their team’s platform and get the most out of the system.
For more information, visit: https://centralcpd.co.uk/
The ophthalmology service, which offers cataract surgery, corrective eyelid surgery and corneal disease management amongst other things, is headed by RCVS and US Ophthalmology Specialist, James Histed (pictured right)
The hospital, which has doubled in size to 30,000ft², now has a purpose-built theatre complex, a new reception and waiting area, 12 additional consulting rooms and a new rehabilitation centre equipped with a water treadmill and a large arena for treatment and gait analysis.
It also has a new lecture theatre where SCVS can deliver its CPD programme and parent company IVC can deliver its intern and residency programme.
The company says that its redevelopment has focused on employee wellbeing, to which end there is a new staff area for the 200-strong team a place to gather, dine and relax.
Kennel space for staff dogs has also been increased to support SCVS’s ‘bring your dog to work’ policy.
The new hospital facility is fully operational and open 24/7 for referrals, supporting colleagues from surrounding vet practices.
www.scvetspecialists.co.uk
Starting in 2022 ‘The context, consequence and prevention of veterinary workplace injuries: a qualitative and quantitative study in the UK’ study aims to explore the context, consequences and behaviours surrounding veterinary workplace injuries - to improve the safety of the profession.
The first phase of the research was a cross-sectional survey of 740 broadly representative veterinary professionals.
Initial analysis, published in Occupational Medicine1, explored how injuries and their context are perceived by veterinary profession.
Themes identified during this phase of analysis were:
CVS says the veterinary industry should take note of the discrepancy of perception of what constitutes work-related injury in its practices and reporting protocols.
Practices may need an individualised approach to minimise their workplace injuries: some may need to work on revisiting their ideas around acceptable risk, whilst others may be good at minimising work-related harm, but have a complex or blame-associated reporting system which needs to be simplified.
Dr. John Tulloch, Lecturer and European Specialist in Veterinary Public Health, at the University of Liverpool who is leading the research, said: “Injuries that occur within veterinary practice can tragically at times be life-changing and are often avoidable.
"The objectives of this study are to understand how veterinary professionals define injuries and to understand what injuries they do or do not deem reportable.
"The results of this stage of the research have been both startling and complex.
"They highlight a profession in drastic need of cultural change and personal attitudes, with respect to injury prevention and mitigation.”
Dr. Imogen Schofield, Director of Clinical Research at CVS, said: “Using these findings, we will be able to develop and strengthen injury prevention measures through safety policy, education, and training.
"We anticipate that this project will result in safer workplaces within the wider veterinary community and, indirectly, in improved animal treatment through a fitter, healthier and safer profession.”
CVS says the research will lead to the development of open access educational tools aimed at promoting injury awareness and prevention.
The tools will focus on understanding why reporting injuries is important, how to develop a culture of accountability without blame, and when to seek medical attention and take time off work.
They will also investigate how to encourage clients to be safety ambassadors, and how to empower colleagues in challenging situations regarding restraint, aggressive patients and equine safety.
In addition, they will look at improving cat handling via International Society of Feline Medicine training and Cat Friendly Clinic accreditation, facilitating a rise in usage of hard hats in equine, and raising awareness of the risks associated with sharps plus sharp bin provision.
Reference:
Does your vet practice or an individual in the team deserve to be recognised for their commitment and dedication to their job? If so, this is your last chance to nominate your practice or colleagues for the Petplan Veterinary Awards held at a glittering award ceremony at BSAVA in April.
You can nominate under four categories:
Alison Andrew, Petplan's Marketing Manager, said: "Nominating your colleagues for an award is a fantastic way of expressing your appreciation for their hard work. The veterinary profession is dedicated to animal welfare and at Petplan we believe that their invaluable care and support deserves special recognition. The 11th annual Petplan Veterinary Awards will bestow great accolades upon the stars of the industry."
Ben Jones was awarded Vet of the Year in 2009. He said: "It was a great honour to be named the 2009 Petplan Vet of the Year and it has had a really positive impact. The award has greatly increased the practice's exposure in the local and national press and we've also been able to use the award to generate our own publicity."
However Ben says the greatest impact of the award has been on his customers: "They were all delighted and I think it gave them a lot of reassurance in the service we provide. It has also generated more business with new clients saying they have come to us because of the award."
Ian Patterson, a partner at St Clair Veterinary Group in Fife, said being named the 2009 Practice of the Year has also had a tremendous impact on their practice. He said: "The award meant so much to everyone right across the practice and the team here is extremely proud of their efforts. It has also given us the opportunity to generate more business through the exposure that the practice has received since winning the award."
You can nominate online at www.petplan.co.uk/vetawards. Remember to also encourage your clients to nominate your team for the contribution you have made to their pets wellbeing.
The Veterinary Benevolent Fund has launched a survey for veterinary surgeons in order to learn more about how the charity is viewed by the profession, and understand how it might improve the support it offers.
Please take part! The survey is anonymous, contains 21 questions and should take no more than 5-10 minutes of your time.
The survey is here: http://freeonlinesurveys.com/rendersurvey.asp?sid=b90tg0mv3vtzpa1965478
The results will be shared in due course.
UK veterinary surgeons strongly prefer recommending branded treatments, according to a survey conducted by specialist advertising agency Masius.
The survey, conducted amongst members of www.vetsurgeon.org, received 725 responses. It gave a conclusive insight to veterinary surgeons' opinions on branding, with 87% of respondents saying that they prefer to recommend a branded POM-V over a generic equivalent.
While branded treatments are clearly preferred over generics, vets recognise that higher prices can be an issue for clients. Price is justified mainly through a higher level of trust in the quality of the product (through extensive trialling). They also cite the added support in the event of client usage issues and the value that clients attach to brands. The cascade is a further factor, requiring the use of licensed drugs.
When it comes to supplements, vets are still in favour of brands, but less so - as the cascade is not a factor. On the issue of price differential, most vets felt that a premium of 10-25% is justifiable for a brand over a generic.
Jonathan Posner, Business Director at Masius said: "As well as the quantitative data, we also got some interesting qualitative comments as well. Looking at these, one can see a range of opinions - from the vets who value the easier client acceptance of brands, to those who feel that their professional care of the patient is paramount and that a generic should be used where it delivers the same benefit as a brand. Client ability to pay was also mentioned as a factor - a generic being more likely to lead to compliance for a client on a tight budget."
The fact that branded products come with better information and marketing support was agreed by the large majority (93%) of respondents.
All the participants in the survey were entered into a draw to win an iPad 2. The winner of the draw was Megan Wood MRCVS (pictured right) from Fife. She said: "The iPad is brilliant; I love it, and am a lucky lady!"
Elanco Companion Animal Health has launched a dermatology e-newsletter called Under The Skin, designed to help veterinary professionals stay informed and up to date on a wide range of skin conditions.
Featuring a guest editor for each edition, experts will review interesting case studies and research papers and discuss diagnosis and treatment options.
The launch issue focuses on otitis and is edited by Dr Peri Lau-Gillard DerMedVet CertVD DipECVD MRCVS, European Specialist in Veterinary Dermatology.
Topics include a review of a clinical case - Pseudomonas otitis in a Cocker Spaniel called Rosie, a video otoscopy before and during Rosie's ear flush, information on antimicrobial resistance (AMR), a discussion on whether to carry out in-house ear cytology, product information on Surolan and a review of the causes of otitis.
The newsletter also features hints and tips on how to prevent contamination of ear medication/ear cleaners, the importance of marking products with expiry dates, information on applying topical ear cleaners/ear medication and owner education on how to apply the medication.
To receive priority notification of future editions of Elanco's 'Under The Skin' e-newsletter, register at www.thewebinarvet.com/elanco
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.
Bimeda has announced the launch of Bilovet, a new tylosin-based antibiotic for cattle and pigs.Padraig Hyland, Head of Technical Veterinary Services at Bimeda said: ''It is with great pleasure that I announce the launch of our much anticipated Bilovet 200 mg/ml solution for injection for cattle and pigs as the latest addition to Bimeda's range of essential antibiotics.
Bilovet contains Tylosin 200 mg/ml and is the second Tylosin-based injectable antibiotic to be licensed for cattle - including dairy cattle - in the UK. Bilovet is licensed in cattle for the treatment of respiratory infections, metritis, mastitis, interdigital necrobacillosis and calf diphtheria as well as a range of pig infections, including enzootic pneumonia, haemorrhagic enteritis, erysipelas, arthritis and metritis".
Bimeda's Head of Bimeda R+D, Xavier Molins said: "Bilovet is a completely new development for a product that includes a new species (cattle). Bimeda have made a significant investment in bringing Bilovet to market, including conducting new Environmental Risk Assessment studies according to current guidelines and regulations.''
For more information, ring 01248 725 400 or email: uksales@bimeda.com
Companion Care is launching a new division to develop a network of joint venture surgeries on high streets around the UK.
Thus far, 62 out of the company's 66 surgeries have been located inside Pets at Home stores. The company says it plans to more than double the number of surgeries over the next 5 years, both within Pets at Home stores and on the high street.
The new surgeries will be branded Companion Care Vets. According to the company, they'll be full service practices featuring the latest equipment, situated in locations which offer clients easy access. Managing director, Jane Balmain, said: "The in-store model we operate has been very successful and offers a unique business proposition based around the customer footfall in Pets at Home stores. We will continue to accelerate the growth in numbers of in-store surgeries as the Pets at Home store footprint expands. "While in-store has been hugely successful and the driver in our growth, we know that there are many vets and veterinary nurses who are interested in a joint venture partnership but whose preference is to have a more traditional looking standalone surgery. To enable us to launch partnerships with these professionals we are developing a standalone surgery network plan. We already have 4 very successful standalone surgeries and we feel now is the right time to develop the stand alone concept as a mainstream business proposition." While the new surgeries will be standalone, Companion Care says they will be affiliated with local local Pets at Home stores to drive client registration and business development.
Jane added: "These stand alone surgeries will offer a unique business proposition due to our Pets at Home relationship. We believe that with this new venture we can offer any potential partner the best of both worlds: a superb in-store surgery with footfall of thousands of customers a month, or a standalone new surgery linked to local store(s) to develop the business. I don't believe any other company can offer this unique proposition."
Is this the warm up for the mother of all high street battles between Companion Care and Vets4Pets?
The poster gives information about things like lillies, chocolate, raisins, fertilisers, weedkillers and adders.
TVM will also be running its annual social media campaign about the most common spring dangers, giving practices digital content which they can share with clients.
To get a poster for your practice, contact your local TVM territory manager or visit https://www.tvm-uk.com/pet-dangers-order-free-display-materials-for-your-practice.
The 2009 edition of the NOAH Compendium Data Sheets for Animal Medicines is now being dispatched, free of charge, to each practice premises.
Meanwhile, the online version of the compendium (www.noahcompendium.co.uk), launched 3 years ago to provide a free and convenient source of information about animal medicines for both prescribers and consumers, has just had its 9 millionth page view. The site gets about 3000 visits a day.
Whilst it is possible to order additional print copies of the compendium, NOAH points out that the online version has the beauty of being updated every week with new products, indications and other data. Plus the site is searchable by active ingredient, species, therapeutic indication or text search.
NOAH chief executive Phil Sketchley said: "We try to make the online Compendium as useful and as quick and easy to use as it can be, and while we have received overwhelmingly positive feedback we are always interested to hear how you think it could work better for you, so we can keep this in mind for any future improvements".
The organisers say that the vision for the WellVet Weekend is to offer a range of sport and wellbeing events which give the opportunity to recharge, refresh and re-energise.
This year, the weekend includes the Tour de Cambridge cycle ride, the WellVet sports day, HiiT (high-intensity interval training) sessions as well as some thought-provoking workshops delivered in collaboration with Vets: Stay, Go, Diversify (www.vsgd.co).
The WellVet Mindful stream aims to bring a mellow approach to the weekend with yoga and meditation alongside some reflective workshop-based sessions.
This year also sees the addition of the WellVet Family stream, which will focus on supporting new parents returning to practice, and building mind and body confidence after welcoming a new addition to the family.
The weekend will include plenty of social time, with a gala dinner on Saturday night where the headline speaker is none other than the ultrarunning veterinary surgeon, Jasmin Paris. She'll be giving a speech called 'The Mountains are calling, and so is the baby!' in which she'll talk about her achievement in being the first woman (let alone vet) to win the Montane Spine Race, widely regarded as one of the world’s toughest endurance races. Not only that, but she smashed the overall course record by over 12 hours.
WellVet Co-Founder, Liz Barton, said: "We volunteer a great deal of time and energy to run these not-for-profit events, because of the positive impact it offers individuals. It makes it all worthwhile when we see life-changing experiences from the weekend carried forwards to improve the everyday lives of colleagues within the profession. It’s our way of giving something back. Tickets are subsidised thanks to our generous supporters, making them very affordable and meaning that delegates get a lot of content for their money."
Tickets are now available. For more information and to book your place at WellVet Weekend 2019, please visit www.wellvet.co.uk
Tom graduated from the Royal Veterinary College (RVC) in 2017 and joined Synergy Farm Health full-time in 2018, after completing his postgraduate diploma (PGDipVCP) with the RVC.
Nominated by his practice, Tom is described as a fine example of a dedicated caring professional who is passionate about sustainability, has a keen sense of his clients’ needs, and has developed strong working relationships with the farms under his care.
The judging panel found that Tom uses data effectively in herd health planning to highlight areas of improvement, working in partnership with his clients to promote disease prevention and profitability.
Tom’s clients spoke of his knowledge and caring attitude and how much he is valued as part of their team.
Tom said: “It was a privilege to be a part of the awards and to see farmers and businesses acknowledged - farmers don’t always get the recognition they deserve and seeing British dairying showcased was amazing.
"I hope winning is reward for the time and effort colleagues at Synergy put into young vets too, and that I can put it to good use supporting clients and working with other organisations within the dairy industry.
"My aim as a vet has been simply to support clients the best I could, both clinically and emotionally, so to have won made it a fantastic night and one I won’t be forgetting!”
The runner up as Charlie Mays of LLM Vets, who the judging panel praised for making effective changes on farm towards preventive healthcare and using data to assist with health and profitability.
Charlie also lobbies government to support the interests of the farmer and the industry.
Sabrina Jordan from Virbac said: ‘Virbac has been supporting dairy vets with products and services for over 50 years and recognise the commitment of young dairy vets to the profession.
"The standard of nominations into this category was outstanding, and our winner and highly commended nominees are a true credit to the veterinary profession, both are shining lights of the future’.
The results of the UK's first ever public National Equine Health Survey have quantified non-notifiable healthcare issues affecting horses, ponies, donkeys and mules in the UK.
The survey, which was pioneered by The Blue Cross animal charity and is supported by The British Equine Veterinary Association, was carried out last November following two years of pilot schemes. The intention was to find out more about endemic non-notifiable diseases that have never before been recorded in horses, ponies, donkeys and mules, such as coughs, skin diseases and lameness.
The results were announced at the National Equine Forum by Professor Josh Slater, Professor of Equine Clinical Studies at The Royal Veterinary College, who has been working with The Blue Cross on the survey.
A total of 306 sets of records were submitted from 3120 horses in mainly private ownership, with a balance of representation from competition yards, riding schools, welfare charities and studs. A broad range of syndromes and diseases were assessed including colic, sarcoids, laminitis, wounds, dental issues, eye disease, lameness and weight issues.
The results showed that lameness was the most common problem affecting horses (11% of horses surveyed) but that the foot was not the most common cause of lameness and that laminitis (3%) was less common than the 7-8% total that previous surveys had suggested.
Weight management was the next most common issue for horse owners, with 9% of horses recorded as overweight and 8% as underweight. These figures are lower than previous surveys which may be because they are based on the owner's assessment of their horse's weight which is subjective and may vary according to their perception of 'the right weight'.
Skin disease and wounds (5% and 4% respectively) posed a significant problem and colic (2%) was also a common occurrence, with a 6:1 ratio between medical and surgical cases.
The survey is breaking new ground in Europe as well as the UK. Currently Government agencies in all European countries conduct surveillance for prescribed exotic diseases such as West Nile Virus and African Horse Sickness but currently there are no large scale surveillance programmes for endemic diseases.
Professor Slater said: "The regular collection of such data holds numerous benefits to the UK equine industry. Not only does the survey provide a benchmarking facility for equine disease, welfare, standards of care and codes of practice but it will also underpin standards for yard inspection schemes. Not least it confirms the workability of an important template to monitor the serious threat of infectious and exotic disease in the future."
He added: "It's exciting to see hints in the NEHS 2010 survey that data 'straight from the horse's mouth' might challenge some established ideas. For example; the survey found that lameness was common, as you would expect, but that the foot was not the most common cause of lameness, which you might not have expected. This kind of data has never been collected before and is invaluable to the veterinary profession and wider animal welfare industry, helping to inform our future research, training and education. It will be really exciting to see the results of the larger surveys The Blue Cross are running in 2011."
Kerry Doyle, education officer at The Blue Cross said: "We are thrilled to be involved with this innovative project to enhance the future health of our horses and very grateful to all those who have participated in the survey so far. We now need even more horse owners to sign up for the next round so that we can capture as much useful data as possible."
The National Equine Health Survey is currently funded by The Blue Cross but sponsorship is being sought. It is to be conducted twice-yearly with the next census week planned for 9-15 May 2011. All keepers and owners of horses are urged to participate and details of all horse owners will remain anonymous. It's very quick and easy to complete and should only take around five minutes. To register online visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk.
Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs).
Containing marbofloxacin as its active ingredient, Marboxidin has a taste-masking lipid coating to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food1. Ceva says that Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme.
Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg).
For further details, contact your Ceva Territory Manager or telephone the customer support team on (01494) 781510.
References
The company says the Elekta Infinity linear accelerator is the only one of its kind for pets in England.
It features a multi-leaf collimator for very accurate shaping of the radiation beam and a six-degrees-of-freedom couch top designed so the patient can be positioned to reduce or eliminate radiation doses to critical organs.
CVS says the new machine will allow the centre to offer cutting edge treatments such as stereotactic radiation therapy, where high dose rates of focused beams are delivered with high precision over a shortened treatment course.
This, the company claims, will mean fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital will be at the forefront of cancer care in animals.
“The linear accelerator is state of the art, and allows us to offer advanced, image-guided radiation treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage to these treatments is that they will allow a more “hard-hitting” treatment of the tumour, with greater safety for the patient’s healthy tissue.
"It will draw many tumours into the realm of treatability.”
Based at Central Park, Avonmouth, Bristol Vet Specialists referral hospital is due for completion this Autumn.
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
According to the Pet Food Manufacturers Association, there are an estimated 1M pet rabbits in the UK. They are commonly presented for treatment in practice and clients are beginning to expect complex workups and high levels of veterinary care.
Ivan, who qualified from the RVC in 1999, has been taking on first and second opinion rabbit cases for over 12 years and was instrumental in developing the v-gel anaesthetic device for rabbits and other species (www.docsinnovent.com). Jo has worked in first opinion practice since 2007 and was the Blue Cross Veterinary Nurse of the Year in 2014. Asides from her nursing experience, Jo has been teaching rabbit husbandry and nursing to owners and nurses directly and also via the Rabbit Welfare Association since 2012. Jo and Ivan have also taught rabbit anaesthesia at the Western Veterinary Conference in the USA for the last 3 years as well as lecturing for the Rabbit Welfare Association in the UK.
Ivan said: "We’re trying to get rabbit medicine to be seen as an important CPD subject for vets and nurses. We’re going to be offering day courses and conferences with an enjoyable and challenging mix of small group teaching, problem solving, practical teaching and conventional lectures - making sure that all our courses offer a really enjoyable day out as well as being first class CPD. Our first course is on the 13th October in Berkshire and we’ll be offering many more courses and conferences in the future!"
For more information about LagoLearn and its rabbit CPD, visit: http://www.lagolearn.com